Evercore ISI Issues Pessimistic Forecast for Cardlytics (NASDAQ:CDLX) Stock Price

Cardlytics (NASDAQ:CDLX) had its price target dropped by equities researchers at Evercore ISI from $4.00 to $3.00 in a research report issued on Thursday,Benzinga reports. The firm currently has an “in-line” rating on the stock. Evercore ISI’s price target points to a potential upside of 31.12% from the stock’s previous close.

Separately, Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a report on Thursday. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Cardlytics currently has an average rating of “Hold” and a consensus price target of $6.75.

Cardlytics Trading Up 15.6 %

CDLX stock traded up $0.31 during trading on Thursday, hitting $2.29. The company had a trading volume of 4,402,814 shares, compared to its average volume of 1,062,931. Cardlytics has a 52-week low of $1.77 and a 52-week high of $20.52. The company has a 50 day simple moving average of $3.06 and a 200-day simple moving average of $3.51. The firm has a market capitalization of $116.28 million, a P/E ratio of -0.38 and a beta of 1.62. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40.

Insider Transactions at Cardlytics

In related news, CFO Alexis Desieno sold 24,778 shares of the business’s stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total value of $84,245.20. Following the completion of the sale, the chief financial officer now owns 140,948 shares of the company’s stock, valued at approximately $479,223.20. The trade was a 14.95 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Amit Gupta sold 15,160 shares of the company’s stock in a transaction on Friday, January 24th. The stock was sold at an average price of $3.92, for a total transaction of $59,427.20. Following the transaction, the chief executive officer now owns 215,494 shares of the company’s stock, valued at $844,736.48. This represents a 6.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 111,454 shares of company stock valued at $391,864 in the last three months. 4.40% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Cardlytics

A number of institutional investors and hedge funds have recently bought and sold shares of CDLX. GSA Capital Partners LLP raised its holdings in Cardlytics by 1,273.2% in the 3rd quarter. GSA Capital Partners LLP now owns 382,315 shares of the company’s stock valued at $1,223,000 after buying an additional 354,474 shares during the period. RBF Capital LLC increased its position in shares of Cardlytics by 311.9% during the third quarter. RBF Capital LLC now owns 488,128 shares of the company’s stock worth $1,562,000 after acquiring an additional 369,620 shares during the period. Geode Capital Management LLC raised its stake in shares of Cardlytics by 7.5% in the third quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company’s stock valued at $3,371,000 after acquiring an additional 73,484 shares in the last quarter. Barclays PLC boosted its holdings in Cardlytics by 223.9% in the third quarter. Barclays PLC now owns 58,026 shares of the company’s stock valued at $186,000 after purchasing an additional 40,112 shares during the period. Finally, SG Americas Securities LLC grew its stake in Cardlytics by 38.2% during the 4th quarter. SG Americas Securities LLC now owns 19,490 shares of the company’s stock worth $72,000 after purchasing an additional 5,392 shares in the last quarter. 68.10% of the stock is currently owned by institutional investors and hedge funds.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.